Table: begin end state 1 11 cytoplasmic 12 29 transmembrane 30 38 non-cytoplasmic 39 61 transmembrane 62 83 cytoplasmic 84 110 transmembrane 111 128 non-cytoplasmic 129 148 transmembrane 149 159 cytoplasmic 160 181 transmembrane 182 201 non-cytoplasmic 202 226 transmembrane 227 238 cytoplasmic 239 263 transmembrane 264 292 non-cytoplasmic 293 319 transmembrane 320 330 cytoplasmic 331 351 transmembrane 352 370 non-cytoplasmic 371 388 transmembrane 389 408 cytoplasmic 409 431 transmembrane 432 434 non-cytoplasmic
Input: >WP_013684424.1 NCBI__GCF_000194625.1:WP_013684424.1 MVREKWSSRIGFLLAGIGSAVGLGNVWRFPYIVGQNGGGAFLIPYLISVFLFGLPLMLLE FSTGRLFKGSVVSSLKKIRKKFKWIGIAVVSVLTVVLSYYLVITGWILAFFTFTLLGRET SFESFAQTYFSPLFFVVVTIAASLIVMRGVRKGIEKTSKIMVPALGVLLAVMVIYSLSLP NAMDGITFYLTPDLSKLSDSSIWAAAFGQAFFSLSVGSGILLTYGSYLEEKISLVNSSML ITIFDLLVSFMSGLIVFSIASSFGFEVAAGPKLAFSTLPQVFDKVPYGFFLEGIFFLLLF FAALTSAISMLEIGVAVLIDETSLDRFKSTSLLSSIILVLGFPAALSYSGISLQFTGRPV LDLMDETFGSFGIPLTALLLSTSISWFLDNLVIAEEINKNAKWKIGKTVVFLTRYFIPIV LLYVLLTRLHFYLV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server